Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 28, 2024
Single or continuous multiple intravenous re-induction in Crohn's disease patients who lost response to ustekinumab: Evidence from real-world dataJian Tang, Qing Li, Zhaopeng Huang, et al.BJS Open|November 2, 2022
Impact of long-course neoadjuvant radiation on postoperative low anterior resection syndrome and stoma status in rectal cancer: long-term functional follow-up of a randomized clinical trialSiqi He, Jinquan Zhang, Runxian Wang, et al.Journal of Gastrointestinal Oncology|September 16, 2024
PD-1 blockade combined with chemotherapy and bevacizumab in DNA mismatch repair-proficient/microsatellite stable colorectal liver metastasesQianqian Men, Yinghua Duan, Fengyun Pei, et al.Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|January 17, 2025
Correlation between the Observer's Assessment of Alertness/Sedation score and bispectral index in patients receiving propofol titration during general anesthesia inductionLihong Chen, Huilin Xie, Xia Huang, et al.Insights Into Imaging|October 4, 2025
Creeping fat is associated with transmural healing in patients with Crohn's disease receiving ustekinumabFangling Zhang, Minyi Guo, Pan Zhu, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 15, 2024
Correlation between sarcopenia index and cognitive function in older adult women: A cross-sectional study using NHANES dataYajuan Huang, Rui Zhang, Xinyang Hong, et al.European Radiology|November 5, 2024
Sub-region based histogram analysis of amide proton transfer-weighted MRI for predicting tumor budding grade in rectal adenocarcinoma: a prospective studyPeiyi Xie, Qitong Huang, Litao Zheng, et al.NPJ Precision Oncology|April 24, 2026
Cetuximab plus capecitabine every three weeks as first-line maintenance therapy for RAS/BRAF wild-type metastatic colorectal cancer: a phase Ib dose-escalation studyXiaoyu Xie, Ziqin Lin, Weiwei Li, et al.Journal of Gastrointestinal Oncology|March 14, 2023
Neoadjuvant versus adjuvant imatinib in primary localized gastrointestinal stromal tumorJiayu Ling, Lishuo Shi, Xingyu Cheng, et al.Eclinicalmedicine|November 3, 2025
Neoadjuvant PD-1 blockade with toripalimab with or without celecoxib for patients with mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): long-term outcomes of a single-centre, parallel-group, non-comparative, randomised phase 2 trialXutao Shen, Yue Cai, Weiwei Li, et al.Pageof 5